皮质膜回路作为精神分裂症谱系障碍中可用药物的目标:叙述性审查
Abigail Gee1, Paola Dazzan1, Anthony A Grace2
1Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Translational psychiatry
|January 24, 2025
概括
精神分裂症谱系障碍涉及皮质临床系统功能障碍. 研究强调神经成像和新的方法来理解和治疗这些复杂的症状,改善患者的结果.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 医疗成像医学成像
背景情况:
- 精神分裂症谱系障碍 (SSD) 扰乱了感知,情绪和认知.
- 皮质膜系统对于整合这些功能至关重要.
- 在SSD中,负面和认知症状被当前的药物治疗得很差,并影响长期的结果.
研究的目的:
- 在SSD病理生理学中审查了解皮质膜系统功能障碍的最新进展.
- 探索神经成像和新的方法如何能够跨尺度整合数据.
- 确定SSD的潜在治疗和预防目标.
主要方法:
- 关于SSD中皮质膜功能障碍的最新研究的综合.
- 专注于神经成像技术的进步和多尺度数据集成.
- 整合发现,以告知治疗目标的识别.
主要成果:
- 皮质边膜功能障碍是SSD病理生理学的核心.
- 神经成像和新的方法提供了跨度数据集成的见解.
- 药理干预措施有望改善负面,认知和耐治疗症状.
结论:
- 结合研究模式 (神经成像,实验性干预,联盟) 可以提高对皮质边膜功能障碍的理解.
- 临床转换需要优化干预时间,生物标志物主导的分层和选择性药物.
- 需要进一步的研究来弥合SSD治疗的发现和临床实践之间的差距.
相关概念视频
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
406
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
406
Psychosis and Antipsychotic Drugs: Overview
171
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
171
Psychosis: Goals of Pharmacotherapy
103
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
103
Antipsychotic Drugs: Typical and Atypical Agents
151
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
151
Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37
Biological Causes of Schizophrenia
37
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
37


